HHH discloses director grant: 2,464 restricted shares awarded

Rhea-AI Filing Summary

Howard Hughes Holdings Inc. (HHH) reported an insider equity award. Director Thom Lachman received 2,464 restricted shares of common stock on 10/24/2025 at a $0 grant price under the company’s 2025 Equity Incentive Plan.

The award vests on the earlier of one year from grant or the day of the company’s 2026 annual meeting of stockholders, but not less than 50 weeks. Following this grant, the filing lists 2,464 shares beneficially owned, held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lachman Thomas Cecil

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common stock, $0.01 par value	2,464	$0.00	--

Holdings After Transaction: Common stock, $0.01 par value — 2,464 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lachman Thomas Cecil

(Last) (First) (Middle)

9950 WOODLOCH FOREST DRIVE

SUITE 1100

(Street)

THE WOODLANDS TX 77381

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Howard Hughes Holdings Inc. [ HHH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, $0.01 par value	10/24/2025		A		2,464(1)	A	$0	2,464	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock granted to non-employee directors pursuant to the Issuer's 2025 Equity Incentive Plan. The shares vest on the earlier of one year from the date of grant or the day of the Issuer's 2026 annual meeting of stockholders (but not less than 50 weeks).

	/s/ Nathan Bryce (Attorney-in-Fact for Thom Lachman)	10/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Howard Hughes (HHH) disclose in this Form 4?

A director, Thom Lachman, was granted 2,464 restricted shares on 10/24/2025 at a $0 grant price.

What is the vesting schedule for the HHH director’s restricted stock?

The shares vest on the earlier of one year from grant or the 2026 annual meeting, but not less than 50 weeks.

How many HHH shares does the reporting person own after the transaction?

The filing shows 2,464 shares beneficially owned directly after the reported transaction.

What plan governed the restricted stock grant at HHH?

The award was made under the company’s 2025 Equity Incentive Plan for non-employee directors.

What was the transaction price for the HHH restricted shares?

The grant was reported at a $0 transaction price.

What is the reporting person’s relationship to Howard Hughes (HHH)?

The reporting person is a Director of Howard Hughes Holdings Inc.